BRE 397
Description:
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT PLUS EVEROLIMUS COMPARED WITH EXEMESTANE PLUS EVEROLIMUS IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2- NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Study Status: Approved
Phase Of Study:
BRE 397
Available in 8 location(s)
Description:
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT PLUS EVEROLIMUS COMPARED WITH EXEMESTANE PLUS EVEROLIMUS IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2- NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Locations:
Florida Cancer Specialists East
1309 N. Flagler Drive
West Palm Beach, FL 33401
USA
Get Directions
844-482-4812
Florida Cancer Specialists East
3730 7th Terrace Suite 101
Vero Beach, FL 32960
USA
Get Directions
844-482-4812
Florida Cancer Specialists East
325 Clyde Morris Blvd. Suite 450
Ormond Beach, FL 32174
USA
Get Directions
844-482-4812
Florida Cancer Specialists East
224 Memorial Medical Parkway Suite 300
Dayton Beach, FL 32117
USA
Get Directions
844-482-4812
Florida Cancer Specialists East
1037 State Road 7 Bldg B,Suite 303
Wellington, FL 33414
USA
Get Directions
844-482-4812
Zangmeister Cancer Center
844-482-4812
Zangmeister Cancer Center
844-482-4812
Genesis Cancer and Blood Institute
844-482-4812